Active Ingredient (In Each Tablet)
Dimenhydrinate 50 mg
The following Structured Product Label (SPL) was submitted to the FDA by Allegiant Health for the product Motion Sickness Relief (NDC 69168-408). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, use, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Dimenhydrinate 50 mg
Antiemetic
for prevention and treatment of these symptoms associated with motion sickness:
for children under 2 years of age unless directed by a doctor
taking sedatives or tranquilizers
ask a doctor before use.
In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
| Adults and children 12 years and over |
|
| Children 6 to under 12 years |
|
| Children 2 to under 6 years |
|
croscarmellose sodium, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid
1-888-952-0050 (Monday through Friday 9AM - 5PM EST)
* Please review the disclaimer below.